Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Adenike A Sofoluwe"'
Autor:
Atara I. Ntekim, Abiola Ibraheem, Adenike A. Sofoluwe, Olayinka Kotila, Chinedum Babalola, Theodore Karrison, Christopher O. Olopade
Publikováno v:
JCO Global Oncology, Vol , Iss 6, Pp 983-990 (2020)
Human epidermal growth factor receptor 2 (HER2) subtype of breast cancer is aggressive, leading to a poor outcome. Targeted therapy with trastuzumab has been shown to be effective in the treatment of HER2-positive breast cancer. Cardiotoxicity is a s
Externí odkaz:
https://doaj.org/article/f70c886ae224463c867c0887ac9555e6
Autor:
Atara Ntekim, Abiola Ibraheem, Adenike Adeniyi-Sofoluwe, Toyosi Adepoju, Mojisola Oluwasanu, Toyin Aniagwu, Olutosin Awolude, Williams Balogun, Olayinka Kotila, Prisca Adejumo, Chinedum Peace Babalola, Ganiyu Arinola, Oladosu Ojengbede, Christopher O. Olopade, Olufunmilayo I. Olopade
Publikováno v:
BMC Health Services Research, Vol 20, Iss 1, Pp 1-9 (2020)
Abstract Background There is both higher mortality and morbidity from cancer in low and medium income countries (LMICs) compared with high income countries (HICs). Clinical trial activities and development of more effective and less toxic therapies h
Externí odkaz:
https://doaj.org/article/14443d089cd047f9a892f242c2e8f028
Autor:
Atara Ntekim, Adenike Adeniji-Sofoluwe, Abiola Ibraheem, Anthonia Sowunmi, Ayorinde Folasire, Thomas Olajide, Olalekan Olasehinde, Akinwunmi Komolafe, AbdulRazzak Lawal, Foluso Omodele, Ayodele Sanni, Mustapha Ajani, Olayinka Kotila, Sharifat Folorunsho, Tonyin Aniagwu, Adewumi Alabi, Abiodun Popoola, Chioma Asuzu, Adetola Daramola, Chinedum Babalola, Theodore Karrison, Fatimah Abdulkareem, Olufunmilayo I. Olopade
Publikováno v:
Cancer Research. 83:OT2-21
Background: Populations of African ancestry are underrepresented in global oncology clinical trials resulting in paucity of data on safety and efficacy of cancer medicines in vulnerable Black populations. The ARETTA clinical trial was initiated by th
Autor:
Stella O. Odedina, IkeOluwapo O. Ajayi, Adenike Adeniji-Sofoluwe, Imran O. Morhason-Bello, Dezheng Huo, Olufunmilayo I. Olopade, Oladosu A. Ojengbede
Publikováno v:
BMC Women's Health, Vol 18, Iss 1, Pp 1-11 (2018)
Abstract Background Breast disorders cause great anxiety for women especially when they occur in pregnancy because breast cancer is the most common cause of cancer related deaths in women. Majority of the disorders are Benign Breast Diseases (BBD) wi
Externí odkaz:
https://doaj.org/article/cbbf3ce6bad9400c83bfde289382c95b
Autor:
Olayinka A. Kotila, Theodore Karrison, Adenike A Sofoluwe, Abiola Ibraheem, Atara Ntekim, Christopher O. Olopade, Chinedum P. Babalola
Publikováno v:
JCO Global Oncology
Human epidermal growth factor receptor 2 (HER2) subtype of breast cancer is aggressive, leading to a poor outcome. Targeted therapy with trastuzumab has been shown to be effective in the treatment of HER2-positive breast cancer. Cardiotoxicity is a s
Autor:
Olutosin A. Awolude, Toyin Aniagwu, Olufunmilayo I. Olopade, Olayinka A. Kotila, Christopher O. Olopade, Abiola Ibraheem, Chinedum P. Babalola, Mojisola Oluwasanu, Prisca Olabisi Adejumo, Atara Ntekim, Williams Balogun, Adenike Adeniyi-Sofoluwe, Toyosi Adepoju, Oladosu Ojengbede, Ganiyu O. Arinola
Publikováno v:
BMC Health Services Research, Vol 20, Iss 1, Pp 1-9 (2020)
BMC Health Services Research
BMC Health Services Research
Background There is both higher mortality and morbidity from cancer in low and medium income countries (LMICs) compared with high income countries (HICs). Clinical trial activities and development of more effective and less toxic therapies have led t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ba370afdb592ec7f4c9b8fbeeebb8f0
https://doi.org/10.21203/rs.3.rs-24292/v2
https://doi.org/10.21203/rs.3.rs-24292/v2
Publikováno v:
Brazilian Journal of Oral Sciences; Oct-Dec2016, Vol. 15 Issue 4, p273-279, 7p
Autor:
Wang S; Center for Clinical Cancer Genetics and Global Health, Department of Medicine, University of Chicago, Chicago, Illinois., Ogundiran T; Department of Surgery, College of Medicine, University of Ibadan, Ibadan, Nigeria., Ademola A; Department of Surgery, College of Medicine, University of Ibadan, Ibadan, Nigeria., Olayiwola OA; Department of Pathology, College of Medicine, University of Ibadan, Ibadan, Nigeria., Adeoye A; Department of Pathology, College of Medicine, University of Ibadan, Ibadan, Nigeria., Sofoluwe A; Department of Radiology, University College Hospital, Ibadan, Nigeria., Morhason-Bello I; Center for Population and Reproductive Health, College of Medicine, University of Ibadan, Ibadan, Ibadan, Nigeria., Odedina S; Center for Population and Reproductive Health, College of Medicine, University of Ibadan, Ibadan, Ibadan, Nigeria., Agwai I; Center for Population and Reproductive Health, College of Medicine, University of Ibadan, Ibadan, Ibadan, Nigeria., Adebamowo C; Department of Epidemiology and Preventive Medicine, University of Maryland, Baltimore, Maryland., Obajimi M; Department of Radiology, University College Hospital, Ibadan, Nigeria., Ojengbede O; Center for Population and Reproductive Health, College of Medicine, University of Ibadan, Ibadan, Ibadan, Nigeria., Olopade OI; Center for Clinical Cancer Genetics and Global Health, Department of Medicine, University of Chicago, Chicago, Illinois. dhuo@health.bsd.uchicago.edu folopade@medicine.bsd.uchicago.edu., Huo D; Center for Clinical Cancer Genetics and Global Health, Department of Medicine, University of Chicago, Chicago, Illinois. dhuo@health.bsd.uchicago.edu folopade@medicine.bsd.uchicago.edu.; Department of Public Health Sciences, University of Chicago, Chicago, Illinois.
Publikováno v:
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology [Cancer Epidemiol Biomarkers Prev] 2018 Jun; Vol. 27 (6), pp. 636-643. Date of Electronic Publication: 2018 Apr 20.